Healthcare
Intuitive Surgical, Inc.(ISRG)
Live Price
Offline$402.95
-0.94% today
1Y Change
-19.96%
Window
Jun 23, 2025 โ Jun 1, 2026
- Market Cap
- $162.51B
- Revenue Growth
- +20.5%
- EPS Growth
- +22.3%
- Dividend Yield
- 0.0%
Coverage: 236 bars ยท Jun 23, 2025 โ Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Intuitive Surgical, Inc. (ISRG) is a Healthcare stock with a market cap of $162.51B and listed on NASDAQ. The stock last traded around $402.95 and down 20.0% across the available one-year price window (Jun 23, 2025 โ Jun 1, 2026). Baseline metrics include revenue growth of +20.5%, EPS growth of +22.3%, a dividend yield of 0.0%. What stands out right now is revenue +20.5%, EPS +22.3%, free cash flow +91.0% with operating margin 30.5% and ROIC 16.5%. Valuation already assumes a fairly strong business story at P/E 54.7 and price/sales 15.4. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines ISRG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+20.5% vs +7.6% peer median
Operating Margin
Above sector median
+30.5% vs +19.4% peer median
P/E
Above sector median
54.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 28, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +20.5% and EPS at +22.3%, with operating margin around 30.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.7% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 28, 2026 | โ | -2.7% | -3.3% | -10.3% |
2026 Jan 22, 2026 | +11.4% | -0.3% | -3.5% | -4.1% |
2025 Oct 21, 2025 | +20.6% | +13.9% | +17.9% | +18.2% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ISRG
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
ISRG Max Drawdown
-30.46%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ISRG and SPY.
Company Overview
Intuitive Surgical, Inc.
NASDAQ Global Select
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
- Leadership
- David J. Rosa
- IPO Date
- Jun 16, 2000
- Employees
- 15.6k
- Street Address
- 1020 Kifer Road
- Mailing
- Sunnyvale, CA, 94086-5304
- Region
- Sunnyvale, CA, US
- Reporting Currency
- USD
- Investor Line
- 408 523 2100
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 54.7
- EV/EBITDA
- 42.7
- Price/Sales
- 15.4
- Price/Book
- 9.3
Growth
- Revenue
- +20.5%
- EPS
- +22.3%
- Free Cash Flow
- +91.0%
Profitability
- Gross Margin
- 66.3%
- Operating Margin
- 30.5%
- Net Margin
- 28.2%
- ROE
- 17.0%
- ROIC
- 16.5%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 6.03
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.